From Financial Modeling Prep: 2025-02-13 13:00:04

Bruker Corporation (NASDAQ:BRKR) outperformed in Q4 2024, reporting an EPS of $0.76, surpassing the estimated $0.75, and revenue of $979.6 million, a 14.6% increase from the previous year. Despite a high P/E ratio of 66.91, Bruker’s ability to exceed revenue expectations showcases its strength in the market against competitors like Thermo Fisher Scientific and Agilent Technologies.



Read more at Financial Modeling Prep:: Bruker Corporation’s Financial Performance Analysi…